Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-NT5C1A Antibody (R4D14)

Catalog #:   RHP07301 Specific References (34) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IHC
Accession: Q9BXI3
Overview

Catalog No.

RHP07301

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IHC: 1:100-1:200

Target

Cytosolic 5'-nucleotidase 1A, NT5C1A, cN1A, cN-IA, cN-I, Cytosolic 5'-nucleotidase IA

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9BXI3

Applications

IHC

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R4D14

Data Image
  • Immunohistochemical
    IHC-P analysis of skeletal muscle tissue by NT5C1A antibody (RHP07301). IHC-P was performed using sections of the formalin-fixed paraffin-embedded skeletal muscle tissue;Result: Myocytes are positively stained at the cytoplasm.
References

Characterizing local antibody responses in the muscle of inclusion body myositis patients., PMID:40424896

Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis., PMID:39561568

Impact of sex, age at onset, and anti-cN1A antibodies on sporadic inclusion body myositis., PMID:39126732

High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chain., PMID:38043487

Clinical significance of anti-NT5c1A autoantibody in Korean patients with inflammatory myopathies., PMID:37058449

Anti-Valosin-Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies., PMID:36373433

The decreased serum activity of cytosolic 5'-nucleotidase IA as a potential marker of breast cancer-associated muscle inflammation., PMID:34814800

Pathology Features of Immune and Inflammatory Myopathies, Including a Polymyositis Pattern, Relate Strongly to Serum Autoantibodies., PMID:34363679

Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis., PMID:34313394

Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients., PMID:33974078

Sporadic inclusion body myositis and primary Sjogren's syndrome: an overlooked diagnosis., PMID:33884496

Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies., PMID:33556224

Anti-Cytosolic 5'-Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis., PMID:33497020

Positive Cytosolic 5-Nucleotidase 1A Antibodies in Motor Neuron Disease., PMID:32833724

Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies., PMID:32035011

Effect of intravenous immunoglobulin therapy on anti-NT5C1A antibody-positive inclusion body myositis after successful treatment of hepatitis C: A case report., PMID:31517073

Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis., PMID:31024569

The clinico-serological spectrum of overlap myositis., PMID:30074509

Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus., PMID:29922285

[Sporadic Inclusion Body Myositis and Autoantibodies]., PMID:29632292

Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis., PMID:29363513

Anti-cytosolic 5'-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases., PMID:28954884

Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts., PMID:28687351

Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients., PMID:28283597

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis., PMID:28122761

Sporadic inclusion body myositis misdiagnosed as idiopathic granulomatous myositis., PMID:27692540

Autoantibody targets in vaccine-associated narcolepsy., PMID:27206786

Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases., PMID:25892010

Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement., PMID:25857661

Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases., PMID:25714931

Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility., PMID:24752512

Update in inclusion body myositis., PMID:24067381

Biomarkers of inclusion body myositis., PMID:24067380

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis., PMID:23596012

Datasheet

Document Download

Anti-NT5C1A Antibody (R4D14).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-NT5C1A Antibody (R4D14) [RHP07301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only